Wii Balance Board in Dizziness
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01345422 |
Recruitment Status
:
Withdrawn
(The study never started since it did not receive IRB approval)
First Posted
: May 2, 2011
Last Update Posted
: December 9, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dizziness | Other: Wii Balance Board | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | A Pilot Study to Assess the Usefulness of the Wii Balance Board for Dizziness |

Arm | Intervention/treatment |
---|---|
Experimental: Wii Balance Board
Wii Balance Board Training
|
Other: Wii Balance Board
Participant will undergo Nintendo Wii Balance Board training for two months , five days a week for 30 minutes
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Abnormal posturography exam
Exclusion Criteria:
- Pregnant Women and children

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01345422
Principal Investigator: | David Cheng, MD | Southern California Permanente Medical Group |
Responsible Party: | Kaiser Permanente |
ClinicalTrials.gov Identifier: | NCT01345422 History of Changes |
Other Study ID Numbers: |
HNS1 |
First Posted: | May 2, 2011 Key Record Dates |
Last Update Posted: | December 9, 2015 |
Last Verified: | December 2015 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Plan Description: | this study did not receive IRB approval |
Additional relevant MeSH terms:
Dizziness Vertigo Sensation Disorders Neurologic Manifestations Nervous System Diseases |
Signs and Symptoms Vestibular Diseases Labyrinth Diseases Ear Diseases Otorhinolaryngologic Diseases |